華是科技(301218.SZ):公司產品和業務涉及計算機軟件、物聯網、大數據及人工智能等方面
格隆匯9月18日丨有投資者於投資者互動平台向華是科技(301218.SZ)提問,“請問公司在AI訓練和機器學習領域有何業務和佈局?”,公司回覆稱,公司產品和業務涉及計算機軟件、物聯網、大數據及人工智能等方面,公司自主研發的水上智能卡口系統、三維激光哨兵、電力現場作業安全預警系統、磁芯缺陷檢測機等產品,均有人工智能技術運用;此外,公司已經在運用人工智能技術開發內河船舶輔助駕駛、自主駕駛方面;公司也將不斷進行相應的技術研發及儲備。目前公司暫未用到特斯拉AI訓練平台。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.